Section of Neurology, Hospital Universitario del Sureste, Ronda del Sur 10, E28500, Arganda del Rey (Madrid), Spain.
Department of Medicine-Neurology, Hospital Universitario Príncipe de Asturias, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
J Neurol. 2019 Aug;266(8):1821-1834. doi: 10.1007/s00415-018-9032-3. Epub 2018 Aug 28.
The possibility that alcohol consumption should be considered as a "protective factor" for Parkinson's disease (PD) has been suggested by several case-control studies. However, other case-control studies and data from prospective longitudinal cohort studies have been inconclusive. We carried out a systematic review which included all the eligible studies published on PD risk related with alcohol consumption, and conducted a meta-analysis according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. The systematic review was performed using two databases, and the meta-analysis of the eligible studies with the software Meta-Disc1.1.1. Heterogeneity between studies was tested with the Q-statistic. The meta-analysis included 26 eligible retrospective case-control studies (8798 PD patients, 15,699 controls) and 5 prospective longitudinal cohort studies (2404 PD patients, 600,592 controls) on alcohol consumption and PD. In retrospective case-control studies the frequency of PD patients never drinkers was higher and the frequency of heavy + moderate drinkers was lower [diagnostic OR (95% CI) 1.33(1.20-1.48) and 0.74(0.64-0.85)], respectively, when compared to healthy controls. In contrast, in prospective studies, the differences were not significant with the exception of a trend towards a higher frequency of non-drinkers in PD women and a significantly lower frequency of moderate + heavy drinkers in PD men in those studies which stratified data by gender. The present meta-analysis suggests an inverse association between alcohol consumption and PD, which is supported by the results of case-control studies but not clearly by prospective ones.
一些病例对照研究表明,饮酒可能被视为帕金森病 (PD) 的“保护因素”。然而,其他病例对照研究和前瞻性纵向队列研究的数据尚无定论。我们进行了一项系统评价,其中包括所有与饮酒相关的 PD 风险的合格研究,并根据系统评价和荟萃分析的首选报告项目 (PRISMA) 指南进行了荟萃分析。系统评价使用了两个数据库,并使用 Meta-Disc1.1.1 软件对合格研究进行荟萃分析。使用 Q 统计量检验研究之间的异质性。荟萃分析包括 26 项合格的回顾性病例对照研究(8798 例 PD 患者,15699 例对照)和 5 项前瞻性纵向队列研究(2404 例 PD 患者,600592 例对照),研究对象为饮酒与 PD 之间的关系。在回顾性病例对照研究中,与健康对照组相比,PD 患者从不饮酒者的频率更高,重度+中度饮酒者的频率更低[诊断 OR(95%CI)1.33(1.20-1.48)和 0.74(0.64-0.85)]。相比之下,在前瞻性研究中,除了在那些按性别分层数据的研究中,PD 女性非饮酒者的频率较高,PD 男性中度+重度饮酒者的频率显著较低外,差异无统计学意义。本荟萃分析表明饮酒与 PD 之间存在反比关系,这一结果得到了病例对照研究的支持,但前瞻性研究的结果并不明确。